Document Detail


Cellular distribution of a mixed MHC class II heterodimer between DRalpha and a chimeric DObeta chain.
MedLine Citation:
PMID:  10050678     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Human MHC class II antigens include HLA-DR, -DQ, and -DP molecules that present antigens to CD4+ T cells, as well as the non-classical molecules HLA-DM and -DO. HLA-DM promotes peptide binding to class II molecules in endocytic compartments and HLA-DO, which is physically associated with HLA-DM in B lymphocytes, regulates HLA-DM function. Antibodies specific for the DObeta chain were obtained by immunization of mice with a heterodimer consisting of a chimeric DObeta chain (DR/DObeta), containing 18 N-terminal residues of DRbeta, paired with the DRalpha chain and isolated from transfected murine fibroblasts. The specificity of this serum for the DObeta chain and the lysosomal expression of the HLA-DO protein was confirmed using mutant human B cell lines lacking DR or DO molecules. The lysosomal localization of HLA-DO in human B cells contrasts with the cell surface expression of the mixed pair in transfected murine fibroblasts and raises questions concerning the role of the putative targeting motifs in HLA-DO. Transfection of the chimeric DR/DObeta chain along with DRalpha into human epithelial HeLa cells resulted in high levels of expression of the mixed isotypic pair at the surface of transfectants as well as in lysosomes. The same pattern was observed in HeLa cells transfected with the DObeta chimera and a DRa chain lacking the cytoplasmic tail. Taken together, these results suggest that functional sorting motifs exist in the DObeta chain but that the tight compartmentalization of HLA-DO observed inside B lymphocytes is controlled by the HLA-DOalpha chain and HLA-DM.
Authors:
A Samaan; J Thibodeau; W Mahana; F Castellino; P A Cazenave; T J Kindt
Related Documents :
3261668 - Differential effect of anti-hla class i monoclonal antibodies on resting and in vivo-in...
2578218 - Functional expression of hla-dp genes transfected into mouse fibroblasts.
18405238 - Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for p...
2728398 - Typing for hla class i gene products using plasma as source.
1500298 - Quantitative immuno-gold labelling and ultrastructural preservation after cryofixation ...
3101368 - Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International immunology     Volume:  11     ISSN:  0953-8178     ISO Abbreviation:  Int. Immunol.     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-05-11     Completed Date:  1999-05-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8916182     Medline TA:  Int Immunol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  99-111     Citation Subset:  IM    
Affiliation:
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibody Specificity
B-Lymphocytes / immunology*
Cell Compartmentation
Cell Fractionation
Cell Line
Dimerization
Endocytosis
Flow Cytometry
HLA-D Antigens / immunology,  isolation & purification*
HLA-DR Antigens / isolation & purification*
Hela Cells
Histocompatibility Antigens Class II*
Humans
Lysosomes
Major Histocompatibility Complex*
Mice
Recombinant Fusion Proteins / isolation & purification
Chemical
Reg. No./Substance:
0/H-2O antigen; 0/HLA-D Antigens; 0/HLA-DO antigens; 0/HLA-DR Antigens; 0/Histocompatibility Antigens Class II; 0/Recombinant Fusion Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CD45 can act as a negative regulator for the transition from early to late CD4+ CD8+ thymocytes.
Next Document:  Development and function of autospecific dual TCR+ T lymphocytes.